|
ZNF491 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.944400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.102000E-01 |
| Normal-vs-Stage2 |
3.663200E-01 |
| Normal-vs-Stage3 |
5.640100E-02 |
| Normal-vs-Stage4 |
9.402200E-01 |
| Stage1-vs-Stage2 |
2.272000E-01 |
| Stage1-vs-Stage3 |
6.872400E-02 |
| Stage1-vs-Stage4 |
9.669000E-01 |
| Stage2-vs-Stage3 |
4.646000E-02 |
| Stage2-vs-Stage4 |
5.404800E-01 |
| Stage3-vs-Stage4 |
4.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.137000E-01 |
| Normal-vs-AfricanAmerican |
3.311600E-01 |
| Normal-vs-Asian |
8.494000E-01 |
| Caucasian-vs-AfricanAmerican |
3.373400E-01 |
| Caucasian-vs-Asian |
7.364800E-01 |
| AfricanAmerican-vs-Asian |
5.406400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.632800E-01 |
| Normal-vs-Female |
1.254840E-01 |
| Male-vs-Female |
3.390300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.229400E-01 |
| Normal-vs-Extreme_Weight |
9.026200E-01 |
| Normal-vs-Obese |
7.316200E-01 |
| Normal-vs-Extreme_Obese |
5.899400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.386000E-01 |
| Normal_Weight-vs-Obese |
9.364000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.844800E-01 |
| Extreme_Weight-vs-Obese |
6.403200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.278600E-01 |
| Obese-vs-Extreme_Obese |
4.092800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.605400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.329550E-01 |
| Normal-vs-Age(61-80Yrs) |
6.014000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.879800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.152200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.627600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.866200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207750E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.159800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.499400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.102350E-01 |
| Normal-VS-Type2 PRCC |
3.717900E-02 |
| Normal-VS-KIRP CIMP |
3.219200E-03 |
| Normal-VS-Unclassified PRCC |
3.655000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.44979999999284E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.144100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.127400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.331580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.332000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.437590E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.200800E-01 |
| Normal-vs-N1 |
8.373000E-01 |
| Normal-vs-N2 |
4.788000E-02 |
| N0-vs-N1 |
9.142400E-01 |
| N0-vs-N2 |
1.927020E-01 |
| N1-vs-N2 |
3.465600E-01 |
|
|
